Annual Accounts Payable
$3.50 M
+$770.00 K+28.19%
December 31, 2023
Summary
- As of February 20, 2025, CUE annual accounts payable is $3.50 million, with the most recent change of +$770.00 thousand (+28.19%) on December 31, 2023.
- During the last 3 years, CUE annual accounts payable has risen by +$1.43 million (+69.11%).
- CUE annual accounts payable is now at all-time high.
Performance
CUE Accounts Payable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Accounts Payable
$6.47 M
+$2.57 M+65.75%
September 30, 2024
Summary
- As of February 20, 2025, CUE quarterly accounts payable is $6.47 million, with the most recent change of +$2.57 million (+65.75%) on September 30, 2024.
- Over the past year, CUE quarterly accounts payable has increased by +$2.57 million (+65.75%).
- CUE quarterly accounts payable is now at all-time high.
Performance
CUE Quarterly Accounts Payable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Accounts Payable Formula
Accounts Payable = Beginning Accounts Payable + Purchases on Credit − Payments to Suppliers
CUE Accounts Payable Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +28.2% | +65.8% |
| 3 y3 years | +69.1% | +137.1% |
| 5 y5 years | +72.0% | +137.1% |
CUE Accounts Payable Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | +35.1% | at high | +312.9% |
| 5 y | 5-year | at high | +296.6% | at high | +633.4% |
| alltime | all time | at high | +296.6% | at high | +1085.7% |
Cue Biopharma Accounts Payable History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $6.47 M(+65.7%) |
| Jun 2024 | - | $3.91 M(-0.3%) |
| Mar 2024 | - | $3.92 M(+11.9%) |
| Dec 2023 | $3.50 M(+28.2%) | $3.50 M(+41.2%) |
| Sep 2023 | - | $2.48 M(+5.3%) |
| Jun 2023 | - | $2.36 M(+9.5%) |
| Mar 2023 | - | $2.15 M(-21.2%) |
| Dec 2022 | $2.73 M(+5.4%) | $2.73 M(+33.5%) |
| Sep 2022 | - | $2.04 M(+30.4%) |
| Jun 2022 | - | $1.57 M(-40.1%) |
| Mar 2022 | - | $2.62 M(+1.0%) |
| Dec 2021 | $2.59 M | $2.59 M(+4.9%) |
| Sep 2021 | - | $2.47 M(-17.4%) |
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2021 | - | $2.99 M(+18.6%) |
| Mar 2021 | - | $2.52 M(+21.9%) |
| Dec 2020 | $2.07 M(+134.5%) | $2.07 M(+86.9%) |
| Sep 2020 | - | $1.11 M(-14.0%) |
| Jun 2020 | - | $1.29 M(-25.9%) |
| Mar 2020 | - | $1.74 M(+97.1%) |
| Dec 2019 | $882.70 K(-56.6%) | $882.70 K(-25.1%) |
| Sep 2019 | - | $1.18 M(-48.5%) |
| Jun 2019 | - | $2.29 M(-20.9%) |
| Mar 2019 | - | $2.89 M(+42.1%) |
| Dec 2018 | $2.04 M(+22.7%) | $2.04 M(+104.2%) |
| Sep 2018 | - | $997.00 K(+82.6%) |
| Jun 2018 | - | $546.00 K(-67.1%) |
| Dec 2017 | $1.66 M | $1.66 M |
FAQ
- What is Cue Biopharma annual accounts payable?
- What is the all time high annual accounts payable for Cue Biopharma?
- What is Cue Biopharma annual accounts payable year-on-year change?
- What is Cue Biopharma quarterly accounts payable?
- What is the all time high quarterly accounts payable for Cue Biopharma?
- What is Cue Biopharma quarterly accounts payable year-on-year change?
What is Cue Biopharma annual accounts payable?
The current annual accounts payable of CUE is $3.50 M
What is the all time high annual accounts payable for Cue Biopharma?
Cue Biopharma all-time high annual accounts payable is $3.50 M
What is Cue Biopharma annual accounts payable year-on-year change?
Over the past year, CUE annual accounts payable has changed by +$770.00 K (+28.19%)
What is Cue Biopharma quarterly accounts payable?
The current quarterly accounts payable of CUE is $6.47 M
What is the all time high quarterly accounts payable for Cue Biopharma?
Cue Biopharma all-time high quarterly accounts payable is $6.47 M
What is Cue Biopharma quarterly accounts payable year-on-year change?
Over the past year, CUE quarterly accounts payable has changed by +$2.57 M (+65.75%)